The appears to the abortion pill mifepristone nationwide, but should they rule in favor of the Food and Drug Administration, it does not mean the pill would become universally available in the United States.Justices heard oral arguments in the pivotal case v. Alliance for Hippocratic Medicine on Tuesday and will likely issue their decision in late June or early July before going on recess. The consequential case has the potential to impact abortion access not just in states that have moved to further restrict or ban abortion since Roe v. Wade was overturned in 2022 but also states where abortion rights are protected or have even been expanded.
Load More
Load More